These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3582783)
1. Nonenzymatic glycosylation of serum IgG and its effect on antibody activity in patients with diabetes mellitus. Kaneshige H Diabetes; 1987 Jul; 36(7):822-8. PubMed ID: 3582783 [TBL] [Abstract][Full Text] [Related]
2. Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy. Kalia K; Sharma S; Mistry K Clin Chim Acta; 2004 Sep; 347(1-2):169-76. PubMed ID: 15313155 [TBL] [Abstract][Full Text] [Related]
4. Nonenzymic glycation of apolipoprotein B in patients with insulin- and noninsulin-dependent diabetes mellitus. Panteghini M; Cimino A; Pagani F; Girelli A Clin Biochem; 1995 Dec; 28(6):587-92. PubMed ID: 8595706 [TBL] [Abstract][Full Text] [Related]
5. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R mBio; 2017 Sep; 8(5):. PubMed ID: 28928215 [TBL] [Abstract][Full Text] [Related]
6. Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA). Newkirk MM; LePage K; Niwa T; Rubin L Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1129-38. PubMed ID: 9846895 [TBL] [Abstract][Full Text] [Related]
7. Serum immunoglobulin levels in type 2 diabetes patients with chronic periodontitis. Awartani F J Contemp Dent Pract; 2010 May; 11(3):001-8. PubMed ID: 20461318 [TBL] [Abstract][Full Text] [Related]
9. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine? Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584 [TBL] [Abstract][Full Text] [Related]
10. Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination. Ali H; Alterki A; Sindhu S; Alahmad B; Hammad M; Al-Sabah S; Alghounaim M; Jamal MH; Aldei A; Mairza MJ; Husain M; Deverajan S; Ahmad R; Cherian P; Alkhairi I; Alkandari A; Abubaker J; Abu-Farha M; Al-Mulla F Front Immunol; 2021; 12():752233. PubMed ID: 34899701 [TBL] [Abstract][Full Text] [Related]
11. Short-term responses to periodontal therapy in insulin-dependent diabetic patients. Smith GT; Greenbaum CJ; Johnson BD; Persson GR J Periodontol; 1996 Aug; 67(8):794-802. PubMed ID: 8866319 [TBL] [Abstract][Full Text] [Related]
12. The sequential appearance of antibody and immunoglobins in nasal secretion after immunization of volunteers with live and inactivated influenza B virus vaccines. Downie JC J Hyg (Lond); 1973 Sep; 71(3):433-45. PubMed ID: 4518342 [TBL] [Abstract][Full Text] [Related]
13. Metformin-induced suppression of IFN-α via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in type 2 diabetes. Saenwongsa W; Nithichanon A; Chittaganpitch M; Buayai K; Kewcharoenwong C; Thumrongwilainet B; Butta P; Palaga T; Takahashi Y; Ato M; Lertmemongkolchai G Sci Rep; 2020 Feb; 10(1):3229. PubMed ID: 32094377 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination. Manenti A; Tete SM; Mohn KG; Jul-Larsen Å; Gianchecchi E; Montomoli E; Brokstad KA; Cox RJ Vaccine; 2017 Jan; 35(1):191-198. PubMed ID: 27789145 [TBL] [Abstract][Full Text] [Related]
15. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration. de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989 [TBL] [Abstract][Full Text] [Related]
16. Serum anti-streptococcal IgA, IgG and IgM antibodies in IgA-associated diseases. Nakatsuka K Acta Paediatr Jpn; 1993 Apr; 35(2):118-23. PubMed ID: 8503268 [TBL] [Abstract][Full Text] [Related]
17. IgG and IgM responses to human papillomavirus L1 virus-like particle as a function of dosing schedule and vaccine formulation. Park MH; You JW; Kim HJ; Kim HJ J Microbiol; 2019 Sep; 57(9):821-827. PubMed ID: 31452045 [TBL] [Abstract][Full Text] [Related]
18. Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus. Diepersloot RJ; Bouter KP; Beyer WE; Hoekstra JB; Masurel N Diabetologia; 1987 Jun; 30(6):397-401. PubMed ID: 3678660 [TBL] [Abstract][Full Text] [Related]
19. Total IgG and IgG subclass specific antibody responses to insulin in diabetic patients. Soto-Aguilar MC; deShazo RD; Morgan JE; Mather P; Ibrahim G; Frentz JM; Lauritano AA Ann Allergy; 1991 Nov; 67(5):499-503. PubMed ID: 1958003 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of Cu,Zn-superoxide dismutase by in vitro glycosylation and in erythrocytes of diabetic patients. Oda A; Bannai C; Yamaoka T; Katori T; Matsushima T; Yamashita K Horm Metab Res; 1994 Jan; 26(1):1-4. PubMed ID: 8150417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]